Mr. Doron Nevo - Chairman

Mr. Nevo has founded and served as President and CEO of a number of companies, including KiloLambda Technologies, Ltd., an optical components and subsystems company, NKO, Inc., a company that designed and developed a carrier-grade IP Telephony system platform and established its own IP network, and Clalcom Ltd., where he founded a leading Israeli international telecommunication carrier, Barak, Ltd. Prior to Clalcom, Doron held various positions with Sprint International, Inc. He serves on the Board of Directors of a number of companies in various fields, including Audiocodes, Ltd., Elcom Technologies, Notox, Ltd. and Etgar Portfolio Management Trust Co. Mr Nevo holds a B.Sc. in Electrical Engineering from the Technion - Israel's Technology Institute and an M.Sc. in Telecommunications Management from Brooklyn Polytechnic. 

Prof. Avraham Hochberg, Ph.D.

Prof. Hochberg was born in Haifa in 1938. He served in the Israeli Defense Forces, reaching the rank of Lieutenant-Colonel. He received his Ph.D. summa cum laude from the Hebrew University of Jerusalem, Israel, and has been a member of the academic faculty for over 48 years. He has served as Chief Scientific Officer of BioCancell since founding it in 2004. A biochemist and molecular biologist in the Department of Biological Chemistry at the University, Prof. Hochberg is recognized as a world-leading expert on the H19 gene, leading the 19-year ground-breaking research. His list of nearly 150 publications covers seminal contributions in the fields of imprinted genes, H19 gene, IGF2 gene and oncology. He also holds a B.A. in Archaeology.

Mr. Aviv Boim

Mr. Boim is the Chief Executive Officer of Tikcro Technologies, Ltd., which he joined from Orckit Communications Ltd., where he held the position of Chief Financial Officer for nearly ten years. Prior to joining Orckit, Mr. Boim was a banker with BT Alex. Brown Incorporated, an investment banking firm. Mr. Boim holds a B.A. and an M.A. in economics and management from Tel Aviv University and an L.L.B. from Tel Aviv University Law School.

Mr. Hanoch Rappaport

Mr. Rappaport is the CFO of the Provident Fund of the Employees of the Hebrew University, Ltd. He has previously served as Investment Manager at A. Heifetz & Co., where he was responsible for the investment process, monitoring portfolio companies and maintaining liaison with a network of private and institutional investors, and before that he was a corporate credit officer at leading Israeli bank, Bank Hapoalim. Mr. Rappaport holds a BA in Economics and Political Science from Bar-Ilan University, an MBA from the Tel Aviv International School of Management and an MBA in Finance from the Hebrew University of Jerusalem, Israel.

Mr. David Schlachet

Mr. Schlachet has served as a director since January 2010. He was previously CEO of Syneron Medical Ltd., Managing Partner of Biocom (a venture capital fund specializing in the life sciences area), senior VP and CFO of Strauss Elite Holdings, VP Finance & Administration of the Weizmann Institute of Science, and CEO of the Weizmann Institute's technology transfer company, Yeda R&D Co. Ltd. Mr. Schlachet holds a B.Sc. in chemical engineering from the Technion, and an MBA (Finance) from the Tel Aviv University.

Ms. Orly Yarkoni

Ms. Yarkoni has served as a director since January 2010. She has amassed over 20 years in the insurance industry, most recently as CEO of IDI (Direct Insurance), Ltd. She has served as a member of the Board of Governors of the Israeli Securities Authority, and currently serves as a director of Peninsula Finance, Ltd., Menorah Mivtachim Insurance, Ltd., Ma'ayanot Eden, Ltd., Plasto-Sac, Ltd. and Amot Investments, Ltd. Ms. Yarkoni holds a B.Sc. (cum laude) in Mathematics from the Hebrew University of Jerusalem, Israel, and is a member of the Israeli Association of Actuaries.